Teriflunomide Tablets 7 mg and 14 mg tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 7 mg and 14 mg tablets
Reference Brands: Aubagio(US & EU)
Category: Multiple sclerosis
Teriflunomide inhibits dihydroorotate dehydrogenase, blocking pyrimidine synthesis and reducing activated T and B cell proliferation. It decreases MS relapses, slows disease progression, and reduces lesion activity. Benefits include oral administration, disease stabilization, fewer relapses, and improved quality of life for patients with relapsing-remitting multiple sclerosis.
Product Description:
Teriflunomide tablets, marketed as Aubagio, are approved in the US by the FDA and in the EU via EMA for relapsing forms of multiple sclerosis (MS). Regulatory approval requires a comprehensive dossier including clinical trial data, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical and quality data for approval, while the EMA ensures compliance with regional safety and manufacturing standards.
Teriflunomide Tablets — third party manufacturing & bulk supply
Teriflunomide Tablets 7 mg and 14 mg tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Teriflunomide Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Teriflunomide Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Teriflunomide is used for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It helps reduce the frequency of relapses and slows the progression of physical disability by modulating the immune system and limiting the proliferation of activated lymphocytes that attack the nervous system.
Teriflunomide is made from the active pharmaceutical ingredient teriflunomide, an immunomodulatory agent that selectively inhibits the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH), which is essential for pyrimidine synthesis in rapidly dividing immune cells.
The main trade name is Aubagio.
Aubagio is marketed by Sanofi. Generic versions of teriflunomide may also be manufactured by other pharmaceutical companies depending on regional approvals.
The generic name is teriflunomide.
The brand name is Aubagio.
Teriflunomide is manufactured in regulated pharmaceutical facilities in the USA, EU, UK, and other countries depending on the manufacturer and marketing authorization holder.
Related Products
Lamotriginevdispersible Tablets
Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg
Form: Tablets(IR & ER)
Reference Brands: Lamictal, Lamictal XR(EU & US)
View Details
Dalfampridine
Strength:
10 mg
Form: Extended-Release tablets (XR)
Reference Brands: Ampyra(US)
View Details
Tizanidine Tablets/Capsules
Strength:
2 mg and 4 mg
Form: Oral Capsules/Tablets
Reference Brands: Zanaflex (US)
View Details
Baclofen Tablets:
Strength:
10 mg and 20 mg
Form: Tablet
Reference Brands: Lioresal, Gablofen(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
